甲状腺滤泡状癌患者的临床治疗及预后因素分析  

Analysis of Clinical Treatment and Prognostic Factors of Patients with Thyroid Follicular Carcinoma

作　　者：梁景峰[1] 张宇曦[2] 

机构地区：[1]辽宁省铁岭市银州区医院外科,辽宁铁岭112000 [2]中国医科大学附属第一医院,辽宁沈阳110001

出　　处：《中外医疗》2016年第23期72-74,共3页China & Foreign Medical Treatment

摘　　要：目的探讨甲状腺滤泡状癌的治疗措施及预后因素。方法方便选取该院将2012年4月—2015年6月收治确诊的75例甲状腺泡状癌患者作为研究对象,回顾性分析患者的临床资料,总结临床治疗措施和预后影响因素。结果随访8年内,患者生存率为66.67%;影响患者预后的危险因素有年龄、肿瘤生长方式、肿瘤直径、肿瘤切除程度、临床分期、脉管瘤栓等。结论科学选择术式能够延长生存时间,改善患者预后情况。Objective To investigate the treatment and prognostic factors of thyroid follicular carcinoma. Methods Conve-nient selection in our hospital from April 2012 to June 2015, 75 cases of patients with thyroid bulb carcinoma were treated as the research object. The clinical data of the patients were analyzed retrospectively, and the clinical treatment measures and the influencing factors of the prognosis were summarized. Results The survival rate was 66.67% in 8 years. The risk factors influencing the prognosis were age, tumor growth pattern, tumor diameter, tumor resection degree, clinical stage, vas-cular tumor thrombus, and so on. Conclusion Scientific selection can prolong the survival time and improve the prognosis of patients.

关 键 词：甲状腺滤泡状癌 临床治疗 预后因素 

分 类 号：R4[医药卫生—临床医学]